At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
1 other identifier
observational
17,667
1 country
1
Brief Summary
We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 23, 2013
CompletedFirst Posted
Study publicly available on registry
August 29, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedApril 18, 2024
April 1, 2024
10.8 years
August 23, 2013
April 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biospecimen & Clinical Data Collection
To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results
10 years
Study Arms (2)
Health Condition
Collect blood and other optional biospecimens from participants with a diagnosed health condition
Healthy Control
Collect blood and other optional biospecimens from participants that have not been diagnosed with a health condition
Eligibility Criteria
Diagnosed with a health condition
You may qualify if:
- All adults 18-100 years old
- Able to provide proof of diagnosis
- Live in USA
You may not qualify if:
- Younger than 18 years old
- Receipt of blood products within 30 days of study blood collection
- Receipt of investigational drug within 30 days of study blood collection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sanguine Biosciences
Los Angeles, California, 91403, United States
Biospecimen
Whole blood, serum, plasma, PBMC, RNA, DNA, saliva, stool, hair, skin, CSF, synovial fuid, tumor tissue, urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Houman Hemmati, MD
Sanguine Biosciences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2013
First Posted
August 29, 2013
Study Start
July 1, 2013
Primary Completion
April 1, 2024
Study Completion
April 1, 2024
Last Updated
April 18, 2024
Record last verified: 2024-04